Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-20 Sale | 2024-02-21 9:48 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 12,053 | $14.11 | $170,124 | 142,332 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 4:18 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 39,886 | $15.01 | $598,661 | 66,160 (Direct) | View |
| 2023-11-20 Sale | 2023-11-21 4:32 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,113 | $8.2293 | $58,535 | 83,228 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 8:06 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,142 | $10.73 | $76,624 | 83,049 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 9:20 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,604 | $10.14 | $26,416 | 112,066 (Direct) | View |
| 2023-02-17 Sale | 2023-02-23 5:42 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,727 | $7.66 | $20,889 | 58,768 (Direct) | View |
| 2022-11-18 Sale | 2022-11-21 4:21 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,139 | $5.44 | $6,196 | 59,065 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 5:16 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,145 | $14.96 | $17,130 | 60,204 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 4:56 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $18.07 | $90,328 | 32,969 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 7:55 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $20.52 | $102,579 | 37,969 (Direct) | View |
| 2021-05-03 Sale | 2021-05-06 8:06 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $24.84 | $124,197 | 42,969 (Direct) | View |
| 2021-02-23 Sale | 2021-02-25 8:25 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 15,000 | $33.59 | $503,877 | 47,969 (Direct) | View |
| 2020-10-29 Sale | 2020-11-02 8:01 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $17.48 | $87,394 | 62,969 (Direct) | View |
| 2020-10-20 Sale | 2020-10-22 5:36 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 13,986 | $17.82 | $249,167 | 67,969 (Direct) | View |
| 2020-10-16 Sale | 2020-10-20 2:14 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 914 | $17 | $15,539 | 81,955 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 5:18 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 100 | $17.1 | $1,710 | 82,869 (Direct) | View |
| 2019-12-20 Sale | 2019-12-26 5:32 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $17.02 | $45,025 | 170,359 (Direct) | View |
| 2019-12-12 Sale | 2019-12-16 7:34 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 4,709 | $17.05 | $80,269 | 360,597 (Direct) | View |
| 2019-07-22 Sale | 2019-07-24 5:53 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $18.35 | $134,930 | 177,714 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-17 Exercise | 2024-02-21 9:48 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 37,576 | $0 | 142,332 (Direct) | View |
| 2024-02-11 Option Award | 2024-02-13 09:11 am | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 89,167 | $0 | 135,213 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-21 4:32 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 22,994 | $0 | 83,228 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-21 8:06 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 22,988 | $0 | 83,049 (Direct) | View |
| 2023-02-17 Exercise(A) | 2023-05-22 9:40 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,430 | $0 | 26,736 (Direct) | View |
| 2023-01-11 Option Award | 2023-05-19 9:20 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 29,166 | $0 | 112,066 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 9:20 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 8,410 | $0 | 112,066 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-23 5:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 8,408 | $0 | 58,768 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:21 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,774 | $0 | 59,065 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 5:16 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,773 | $0 | 60,204 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:57 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 47,300 | $0 | 47,300 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:26 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:35 pm | N/A 2029-05-15 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 51,000 | $0 | 51,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:13 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-26 5:32 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $0 | 170,359 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-26 5:32 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $0.0043 | 170,359 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 4,709 | $0 | 360,597 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 4,709 | $0.0043 | 360,597 (Direct) | View |
| 2019-07-22 Exercise | 2019-07-24 5:53 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $0 | 177,714 (Direct) | View |
| 2019-07-22 Exercise | 2019-07-24 5:53 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $0.0043 | 177,714 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-17 5:34 pm | N/A 2029-05-14 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 27,900 | $0 | 27,900 (Direct) | View |